Definiens Announces Expansion to North America
Definiens AG announced the opening of a wholly owned U.S. subsidiary, Definiens Inc., which closely follows the company's global expansion plan. This momentous growth is also due to an increased demand for Definiens' products and solutions, as well as part of an effort to continue the high level of services and support that Definiens' customers have come to expect and appreciate. Additionally, the U.S. and European offices have been undergoing an increase in staff in order to support the growing demand for the new products and solutions. To better serve its customers Definiens will open offices in Boston (Massachusetts) and Boulder (Colorado).
"Definiens is experiencing significant growth in the U.S. for its image intelligence software solutions and services," said Thomas Heydler, Definiens' CEO. "Our expansion into the United States is a major step in developing our international business. A U.S.-based branch will enable us to expand our presence in our most important market and demonstrates our commitment to our North American customers."
"Definiens is now increasingly focusing on developing the next generation of image intelligence solutions such as for high-content screening, histopathology, and diagnostics in the Life Sciences market, and for urban analysis, forestry and military/security purposes in the Geospatial market," Heydler adds. "Our new facilities in the U.S. will give us access to 'best of the best' scientific and business communities in one of the world's most innovative areas. Furthermore we will be able to strengthen our current partnerships and be closer to our growing base of North American clients."
The Company will retain its main offices in Munich (Germany) which houses its R&D and the European operations.
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
